The association between baseline viral load and long-term risk in patients with COVID-19 in Hong Kong: a territory-wide study
COVID-19 can increase the long-term risk of multiorgan dysfunction. Few studies investigated the long-term risk in Asian populations or investigated the association between viral load and long-term risk. We aimed to investigate the post-discharge rates of hospitalization and association with baseline viral load in all patients with COVID-19 in Hong Kong. This was a population-based cohort study included all patients with a positive RT-PCR test for SARS-CoV-2 in Hong Kong between January 1st 2020 and August 30th 2020, routinely admitted to public health care facilities for isolation and treatment. Viral Ct values were available in 3433 (85%) of patients. Outcomes of interest included death, cause-specific hospitalizations, and initiation of medication from the Hospital Authority's territory-wide electronic health records from the Clinical Data Analysis and Reporting System. In total, 4054 people in Hong Kong tested positive for COVID-19 and were admitted to a public health care facility, of whom 167 (4.1%) were admitted to ICU. During a median follow-up time of 251 (interquartile range 240-279) days, 408 (11.9%) were hospitalized for any reason and 16 (0.5%) patients died. After discharge, patients were most often readmitted for respiratory reasons, followed by gastro-intestinal reasons. A higher viral load (lower RT-PCR Ct values) was associated with a higher likelihood of death (Hazard ratio [HR] 5.86, 95% Confidence interval [CI] 2.57-13.33), hospitalization (HR 1.22, 95%CI 1.08-1.39) or hospitalization for cardiovascular disease (HR 12.78, 95%CI 3.67-44.48). Patients with higher viral loads more likely started ACE-inhibitors (HR 1.37, 95%CI 1.12-1.68) and non-opioid analgesics (HR 1.01, 95%CI 1.01-1.23). In a relatively mild COVID-19 population from Hong Kong, the post-acute risk of complications was substantial. Our results highlight that higher viral load predict post-acute complications in patients with relatively mild disease.
Authors
- Mei‐Zhen Wu
- Kelvin Kai‐Wang To (ORCID: https://orcid.org/0000-0002-1921-5824)
- Q W Ren (ORCID: https://orcid.org/0000-0003-0712-9299)
- Wouter Ouwerkerk (ORCID: https://orcid.org/0000-0002-2000-9358)
- Chanchal Chandramouli (ORCID: https://orcid.org/0000-0001-8256-902X)
- Hung‐Fat Tse (ORCID: https://orcid.org/0000-0002-9578-7808)
- Carolyn S.P. Lam (ORCID: https://orcid.org/0000-0003-1903-0018)
- Jasper Tromp (ORCID: https://orcid.org/0000-0001-6043-0713)
- Tiew‐Hwa Katherine Teng (ORCID: https://orcid.org/0000-0002-8431-9961)
- K. Teramoto (ORCID: https://orcid.org/0000-0002-4217-9497)
- Pui‐Fai Wong (ORCID: https://orcid.org/0000-0002-2936-4831)
- Jiayi Huang (ORCID: https://orcid.org/0000-0002-4810-2909)
- Kai Hang Yiu (ORCID: https://orcid.org/0000-0003-2145-3108)
- I J Hung
Institutions
- University Medical Center Groningen (NL)
- National University of Singapore (SG)
- University of Groningen (NL)
- Queen Mary Hospital (CN)
- Duke-NUS Medical School (SG)
- University of Hong Kong - Shenzhen Hospital (CN)
- National Heart Centre Singapore (SG)
- National University Health System (SG)
- University of Amsterdam (NL)
- University of Hong Kong (HK)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1038/s41598-024-65764-0
- Citations
- 5
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.95